Michael Derby
CIK 1809613 · Executive Chairman · last filed 2023-11-29
Michael Derby is an Executive Chairman who has filed 12 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider sold $190 of PXMD on Nov 29, 2023. Across all open-market trades the lifetime net is +$383.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $229 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$229
2
12
$383.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PXMD | Executive Chairman | 457,224 | $0.00 | $229 | $383.5K | 10 | 2023-11-29 |
| Grace Therapeutics, Inc. (ACST) Delisted | Director | — | $3.37 | — | $0 | 2 | 2023-07-18 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-29 | PXMD | Sell (S) | −185 | -$190 | EDGAR |
| 2023-10-30 | PXMD | Sell (S) | −9,175 | -$1.7K | EDGAR |
| 2023-08-30 | PXMD | Sell (S) | −13,540 | -$6.6K | EDGAR |
| 2023-07-28 | PXMD | Tax (F) | −6,272 | -$4.5K | EDGAR |
| 2023-07-18 | Grace Therapeutics, Inc. (ACST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-28 | PXMD | Tax (F) | −6,272 | -$10.1K | EDGAR |
| 2023-04-14 | PXMD | Grant (A) | +150,000 | $0 | EDGAR |
| 2023-03-09 | PXMD | Sell (S) | −2,143 | -$3.1K | EDGAR |
| 2023-03-07 | PXMD | Sell (S) | −28,962 | -$47.2K | EDGAR |
| 2023-03-03 | PXMD | Sell (S) | −29,465 | -$56.4K | EDGAR |